✦ LIBER ✦

Questioning the aim of CML therapy in the era of Imatinib?

✍ Scribed by Carella, A M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Introduction: CML in the imatinib era

✍ R. Hehlmann 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Impact of timing of allogeneic stem cell

✍ M. Schleuning; D. Judith; I. Burlakova; H. Baurmann; R. Schwerdtfeger 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Surpassing the success of imatinib mesyl

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Excellent outcomes of children with CML

✍ Hideki Muramatsu; Yoshiyuki Takahashi; Hirotoshi Sakaguchi; Akira Shimada; Nobuh 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 250 KB

Knockdown of SOD1 sensitizes the CD34+ C

✍ Li Liu; Renan Chen; Siyong Huang; Yanlan Wu; Guohui Li; Qiang Liu; Dandan Yin; Y 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 230 KB

Prognostic factors for outcomes in allog

✍ Khoury, H J; Kukreja, M; Goldman, J M; Wang, T; Halter, J; Arora, M; Gupta, V; R 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB